+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05265169

Microwave Ablation Treatment for Up to Three Colorectal Liver Metastases with Confirmed Margins A Prospective Study to Achieve Local Tumor Control and Reduce Progression

Led by Society of Interventional Oncology · Updated on 2024-01-17

275

Participants Needed

7

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating microwave ablation MWA as a potential curative treatment for patients with up to three colorectal liver metastases CLM, each measuring 2.5 cm or less. The study aims to show that MWA can achieve a local progression-free survival rate of at least 90% over two years. This international, prospective, multi-center trial focuses on establishing MWA as a preferred standard of care for selected liver metastases by ensuring adequate ablation margins. Participants will undergo MWA using any FDA cleared or CE marked device, targeting one to three liver metastases. The procedure aims to create an ablation zone with a minimum margin of 5.0 mm, ideally 10 mm, around each tumor to maximize local tumor control. Margin size will be measured immediately after ablation and again 4-8 weeks later using contrast-enhanced CT scans reviewed by an independent core lab with 3D imaging software. If margins less than 5 mm are found, repeat ablation may be performed within 30 days if safe. During the study, participants will be closely monitored with imaging and clinical assessments to evaluate local tumor progression and overall hepatic disease-free survival. Researchers will also track tumor coverage by the ablation zone and any serious adverse events within 90 days post-procedure. The primary outcome is local tumor progression-free survival at 24 months. Secondary outcomes include hepatic progression-free survival, overall survival, and safety measures. The total participation period aligns with these assessments over two years.

CONDITIONS

Brief Title

Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)

Research Team

R

Research Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here